Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)
Thursday, January 27, 2022 from 2:00 PM ET to 3:00 PM ET • Hosted jointly by AST's Kidney Pancreas Community of Practice (KPCOP) and Transplant Pharmacy Community of Practice (TxPharm COP)
"Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)"
(Clinical Trial > Transplantation. 2021 Aug 1;105(8):1808-1817. doi: 10.1097/TP.0000000000003496.)